RPL21P42: A Promising Drug Target / Biomarker (G100271162)

Target Name: RPL21P42

NCBI ID: G100271162

RPL21P42

Other Name(s): Ribosomal protein L21 pseudogene 42 | RPL21_13_421 | ribosomal protein L21 pseudogene 42

RPL21P42: A Promising Drug Target / Biomarker

The protein RPL21P42 is a key regulator of the replication process in eukaryotic cells. It is a member of the RPL21 family of proteins, which are involved in the regulation of DNA replication in various organisms, including humans. P42 is a 21-kDa protein that is expressed in various tissues and cells of the human body.

Function

RPL21P42 plays a critical role in the regulation of DNA replication in the eukaryotic cell. It is involved in the formation of the replication complex, which is the set of proteins and factors that coordinate the process of DNA replication. P42 is a key component of the replication complex, as it helps to ensure the proper assembly and stability of the complex.

One of the key functions of RPL21P42 is its role in the regulation of the timing of DNA replication. P42 is involved in the timing of the G1 phase of the cell cycle, which is the stage of the cell cycle when the cell prepares for DNA replication. During the G1 phase, P42 helps to regulate the level of the protein p21, which is involved in the regulation of the cycle.

In addition to its role in regulating the timing of DNA replication, RPL21P42 is also involved in the regulation of the quality of the DNA replication product. P42 helps to ensure that the DNA replication product is of high quality, which is important for the proper functioning of the cell.

Mutations in RPL21P42 have been observed in various organisms, including humans. These mutations can have a variety of different effects on the function of the protein, including its ability to regulate the timing of DNA replication and its ability to ensure the quality of the DNA replication product.

Drug Targeting

The protein RPL21P42 is a potential drug target in various diseases. For example, RPL21P42 has been shown to be involved in the regulation of the growth and development of cancer cells. In addition, RPL21P42 has also been shown to be involved in the regulation of the immune response, which is important for the fight against infection and disease.

Conclusion

In conclusion, the protein RPL21P42 is a key regulator of the replication process in eukaryotic cells. It plays a critical role in the formation of the replication complex and helps to ensure the proper assembly and stability of the complex. In addition, RPL21P42 is also involved in the regulation of the timing of DNA replication and the quality of the DNA replication product. These functions make RPL21P42 an attractive target for drug development in various diseases.

Protein Name: Ribosomal Protein L21 Pseudogene 42

The "RPL21P42 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL21P42 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets